Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase IIb randomized double-blind placebo-controlled trial of ZED1227 in celiac disease with persistent symptoms despite gluten-free diet
2020-004612-97Phase 2Completed
- Sponsor
- Dr. Falk Pharma GmbH
- Start
- Jun 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in celiac disease comparing ZED1227 arms with Placebo arm (2 arms). Primary endpoint: Multi-component primary endpoint. Started Jun 2021; status: completed.
02
Drugs
ZED1227
03
Conditions
celiac disease
Beyond the preview
Go deeper on 2020-004612-97.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2020-004612-97.